There is provided a compound of Formula I
wherein each T is independently selected from H, hydrocarbyl, —F—R, and a bond with one of D, E, P or Q, or together with one of P and Q forms a ring; Z is a suitable atom the valency of which is m; D, E and F are each independently of each other an optional linker group, wherein when Z is nitrogen E is other than CH
2
and C═O; P, Q and R are independently of each other a ring system; and at least Q comprises a sulphamate group.
The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound of the formula (I):
wherein R1 is lower alkyl, cycloalkyl or the like,
R2 is hydrogen, lower alkyl or the like,
n is 1 or 2,
X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like,
Y is CONR7, CSNR7, NR7CO, NR7CS or the like,
Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like and R7 is hydrogen or lower alkyl,
prodrug, pharmaceutically acceptable salt or solvate thereof
本发明提供了一种用作 NPY Y5 受体拮抗剂的药物组合物,该组合物由式(I)化合物组成:
其中 R1 是低级烷基、环烷基或类似物、
R2 是氢、低级烷基或类似物、
n 是 1 或 2、
X 是低级烯烃、低级烯烃、芳基、环烷烃或类似物、
Y 是 CONR7、CSNR7、NR7CO、NR7CS 或类似物、
Z 是低级烷基、任选取代的碳环烷基、任选取代的杂环烷基或类似物,R7 是氢或低级烷基、
其原药、药学上可接受的盐或溶液
US7361677B2
申请人:——
公开号:US7361677B2
公开(公告)日:2008-04-22
US7745472B2
申请人:——
公开号:US7745472B2
公开(公告)日:2010-06-29
Synthesis of quinoxaline–benzoxale conjugates and mesomorphic properties
作者:Chun-Jung Chen、Yu-Che Wu、Hwo-Shuenn Sheu、Gene-Hsiang Lee、Chung K. Lai
DOI:10.1016/j.tet.2010.11.014
日期:2011.1
A newseries of non-discotic heterocyclic compounds 1a–e derived from quinoxaline was prepared and their mesomorphic properties investigated. The crystal and molecularstructures of nonmesogenic 2,3-bis(3,4-didodecyloxyphenyl)quinoxaline-6-carboxylic acid 4-[(4-butoxy2-hydroxyphenylimino)methyl]phenyl ester 2a (n=4, m=12) were determined by means of X-ray structural analysis. It crystallizes in a monoclinic